Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2098146

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2098146

Drugs of Abuse Testing Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The drugs of abuse testing market is witnessing significant growth due to increasing concerns regarding substance abuse, rising workplace safety requirements, and growing adoption of advanced diagnostic testing technologies. The increasing prevalence of illicit drug consumption and the implementation of strict regulatory frameworks for drug screening are driving demand for accurate and efficient testing solutions. The market is valued at USD 6.8 Bn in 2026 and is projected to reach USD 14.66 Bn by 2033, growing at a CAGR of 12% during the forecast period.

Market Insights:

The industry is undergoing rapid transformation with advancements in immunoassay technologies, chromatography-based testing methods, and portable drug detection devices. Healthcare organizations, law enforcement agencies, and workplaces are increasingly adopting drug testing solutions to ensure safety, compliance, and effective substance abuse monitoring. The development of rapid testing devices with improved accuracy and faster turnaround times is enhancing accessibility across various end-use sectors. Additionally, increasing adoption of automated analyzers and laboratory-based testing platforms is strengthening the efficiency of drug screening processes.

Drivers:

Key drivers of the drugs of abuse testing market include the rising incidence of substance abuse disorders, increasing workplace drug screening programs, and growing government initiatives to control illegal drug use. Organizations across industries are implementing regular employee testing programs to maintain workplace safety and regulatory compliance. The expansion of criminal justice and law enforcement drug testing programs is further supporting market growth. Technological advancements in point-of-care testing devices, improved detection capabilities, and increasing awareness regarding early identification of drug misuse are also contributing to market expansion.

Business Opportunity:

The market presents strong business opportunities for manufacturers developing innovative rapid testing kits, advanced analyzers, and integrated digital drug screening platforms. Increasing demand for portable and cost-effective testing solutions is creating growth prospects, particularly in emerging economies with expanding healthcare infrastructure. Partnerships between diagnostic companies, research laboratories, and government agencies are expected to accelerate the development of next-generation testing technologies. The growing focus on personalized healthcare and preventive substance abuse management is also expected to create new opportunities for market participants.

Region Analysis:

North America dominates the drugs of abuse testing market due to high awareness regarding substance abuse monitoring, established healthcare infrastructure, and strong adoption of workplace and law enforcement testing programs. The presence of leading diagnostic companies and supportive government regulations further strengthens regional growth. Europe holds a significant market share owing to increasing investments in healthcare diagnostics and growing initiatives to address substance misuse. The Asia Pacific region is expected to witness notable growth due to rising healthcare expenditure, increasing awareness of drug testing solutions, and expanding research activities. Latin America and the Middle East & Africa are gradually developing markets, supported by improving healthcare systems and increasing adoption of diagnostic technologies.

Key Players:

  • One Step Detect Associates
  • Abbott Diagnostics
  • Accutech
  • Acon Laboratories Inc.
  • Agilent Technologies
  • Alfa Scientific
  • American Bio Medica
  • Beckman Coulter
  • Biophor Diagnostics
  • Bio-Rad Laboratories

Segmentation:

By Product and Services

  • Analyzers
  • Consumables
  • Rapid Testing Devices
  • Laboratory Services

By Sample Type

  • Urine
  • Oral Fluid (Saliva)
  • Hair
  • Breath
  • Others

By End User

  • Workplaces and Schools
  • Criminal Justice Systems and Law Enforcement Agencies
  • Research Laboratories
  • Hospitals

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Drugs of Abuse Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Drugs of Abuse Testing Market Outlook, 2020-2033

  • 3.1. Global Drugs of Abuse Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Equipment
      • 3.1.1.1. Immunoassay Analyzers
      • 3.1.1.2. Chromatography Instruments
      • 3.1.1.3. Breath Analyzers
    • 3.1.2. Consumables
      • 3.1.2.1. Rapid Test Kits
      • 3.1.2.2. Reagents
      • 3.1.2.3. Others
    • 3.1.3. Global Drugs of Abuse Testing Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
      • 3.1.3.1. Saliva
      • 3.1.3.2. Urine
      • 3.1.3.3. Hair
      • 3.1.3.4. Breath
      • 3.1.3.5. Blood
      • 3.1.3.6. Sweat
    • 3.1.4. Global Drugs of Abuse Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
      • 3.1.4.1. Medical Screening
      • 3.1.4.2. Monitoring Pain Management
      • 3.1.4.3. Forensic & Legal Information
      • 3.1.4.4. Employment Drug Testing
      • 3.1.4.5. Sports & Athletics Testing
    • 3.1.5. Global Drugs of Abuse Testing Market Outlook, by End-User, Value (US$ Bn), 2020-2033
      • 3.1.5.1. Hospital
      • 3.1.5.2. Forensic Labs
      • 3.1.5.3. Diagnostic Centres
      • 3.1.5.4. Speciality Clinics
      • 3.1.5.5. Others
    • 3.1.6. Global Drugs of Abuse Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
      • 3.1.6.1. North America
      • 3.1.6.2. Europe
      • 3.1.6.3. Asia Pacific
      • 3.1.6.4. Latin America
      • 3.1.6.5. Middle East & Africa

4. North America Drugs of Abuse Testing Market Outlook, 2020-2033

  • 4.1. North America Drugs of Abuse Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Equipment
      • 4.1.1.1. Immunoassay Analyzers
      • 4.1.1.2. Chromatography Instruments
      • 4.1.1.3. Breath Analyzers
    • 4.1.2. Consumables
      • 4.1.2.1. Rapid Test Kits
      • 4.1.2.2. Reagents
      • 4.1.2.3. Others
    • 4.1.3. North America Drugs of Abuse Testing Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
      • 4.1.3.1. Saliva
      • 4.1.3.2. Urine
      • 4.1.3.3. Hair
      • 4.1.3.4. Breath
      • 4.1.3.5. Blood
      • 4.1.3.6. Sweat
    • 4.1.4. North America Drugs of Abuse Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
      • 4.1.4.1. Medical Screening
      • 4.1.4.2. Monitoring Pain Management
      • 4.1.4.3. Forensic & Legal Information
      • 4.1.4.4. Employment Drug Testing
      • 4.1.4.5. Sports & Athletics Testing
    • 4.1.5. North America Drugs of Abuse Testing Market Outlook, by End-User, Value (US$ Bn), 2020-2033
      • 4.1.5.1. Hospital
      • 4.1.5.2. Forensic Labs
      • 4.1.5.3. Diagnostic Centres
      • 4.1.5.4. Speciality Clinics
      • 4.1.5.5. Others
    • 4.1.6. North America Drugs of Abuse Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 4.1.6.1. U.S. Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 4.1.6.2. U.S. Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 4.1.6.3. U.S. Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 4.1.6.4. U.S. Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 4.1.6.5. Canada Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 4.1.6.6. Canada Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 4.1.6.7. Canada Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 4.1.6.8. Canada Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
    • 4.1.7. BPS Analysis/Market Attractiveness Analysis

5. Europe Drugs of Abuse Testing Market Outlook, 2020-2033

  • 5.1. Europe Drugs of Abuse Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Equipment
      • 5.1.1.1. Immunoassay Analyzers
      • 5.1.1.2. Chromatography Instruments
      • 5.1.1.3. Breath Analyzers
    • 5.1.2. Consumables
      • 5.1.2.1. Rapid Test Kits
      • 5.1.2.2. Reagents
      • 5.1.2.3. Others
    • 5.1.3. Europe Drugs of Abuse Testing Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
      • 5.1.3.1. Saliva
      • 5.1.3.2. Urine
      • 5.1.3.3. Hair
      • 5.1.3.4. Breath
      • 5.1.3.5. Blood
      • 5.1.3.6. Sweat
    • 5.1.4. Europe Drugs of Abuse Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
      • 5.1.4.1. Medical Screening
      • 5.1.4.2. Monitoring Pain Management
      • 5.1.4.3. Forensic & Legal Information
      • 5.1.4.4. Employment Drug Testing
      • 5.1.4.5. Sports & Athletics Testing
    • 5.1.5. Europe Drugs of Abuse Testing Market Outlook, by End-User, Value (US$ Bn), 2020-2033
      • 5.1.5.1. Hospital
      • 5.1.5.2. Forensic Labs
      • 5.1.5.3. Diagnostic Centres
      • 5.1.5.4. Speciality Clinics
      • 5.1.5.5. Others
    • 5.1.6. Europe Drugs of Abuse Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 5.1.6.1. Germany Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 5.1.6.2. Germany Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 5.1.6.3. Germany Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 5.1.6.4. Germany Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 5.1.6.5. Italy Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 5.1.6.6. Italy Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 5.1.6.7. Italy Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 5.1.6.8. Italy Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 5.1.6.9. France Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 5.1.6.10. France Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 5.1.6.11. France Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 5.1.6.12. France Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 5.1.6.13. U.K. Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 5.1.6.14. U.K. Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 5.1.6.15. U.K. Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 5.1.6.16. U.K. Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 5.1.6.17. Spain Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 5.1.6.18. Spain Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 5.1.6.19. Spain Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 5.1.6.20. Spain Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 5.1.6.21. Russia Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 5.1.6.22. Russia Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 5.1.6.23. Russia Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 5.1.6.24. Russia Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 5.1.6.25. Rest of Europe Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 5.1.6.26. Rest of Europe Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 5.1.6.27. Rest of Europe Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 5.1.6.28. Rest of Europe Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
    • 5.1.7. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Drugs of Abuse Testing Market Outlook, 2020-2033

  • 6.1. Asia Pacific Drugs of Abuse Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Equipment
      • 6.1.1.1. Immunoassay Analyzers
      • 6.1.1.2. Chromatography Instruments
      • 6.1.1.3. Breath Analyzers
    • 6.1.2. Consumables
      • 6.1.2.1. Rapid Test Kits
      • 6.1.2.2. Reagents
      • 6.1.2.3. Others
    • 6.1.3. Asia Pacific Drugs of Abuse Testing Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
      • 6.1.3.1. Saliva
      • 6.1.3.2. Urine
      • 6.1.3.3. Hair
      • 6.1.3.4. Breath
      • 6.1.3.5. Blood
      • 6.1.3.6. Sweat
    • 6.1.4. Asia Pacific Drugs of Abuse Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
      • 6.1.4.1. Medical Screening
      • 6.1.4.2. Monitoring Pain Management
      • 6.1.4.3. Forensic & Legal Information
      • 6.1.4.4. Employment Drug Testing
      • 6.1.4.5. Sports & Athletics Testing
    • 6.1.5. Asia Pacific Drugs of Abuse Testing Market Outlook, by End-User, Value (US$ Bn), 2020-2033
      • 6.1.5.1. Hospital
      • 6.1.5.2. Forensic Labs
      • 6.1.5.3. Diagnostic Centres
      • 6.1.5.4. Speciality Clinics
      • 6.1.5.5. Others
    • 6.1.6. Asia Pacific Drugs of Abuse Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 6.1.6.1. China Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 6.1.6.2. China Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 6.1.6.3. China Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 6.1.6.4. China Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 6.1.6.5. Japan Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 6.1.6.6. Japan Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 6.1.6.7. Japan Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 6.1.6.8. Japan Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 6.1.6.9. South Korea Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 6.1.6.10. South Korea Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 6.1.6.11. South Korea Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 6.1.6.12. South Korea Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 6.1.6.13. India Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 6.1.6.14. India Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 6.1.6.15. India Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 6.1.6.16. India Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 6.1.6.17. Southeast Asia Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 6.1.6.18. Southeast Asia Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 6.1.6.19. Southeast Asia Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 6.1.6.20. Southeast Asia Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 6.1.6.21. Rest of SAO Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 6.1.6.22. Rest of SAO Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 6.1.6.23. Rest of SAO Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 6.1.6.24. Rest of SAO Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
    • 6.1.7. BPS Analysis/Market Attractiveness Analysis

7. Latin America Drugs of Abuse Testing Market Outlook, 2020-2033

  • 7.1. Latin America Drugs of Abuse Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Equipment
      • 7.1.1.1. Immunoassay Analyzers
      • 7.1.1.2. Chromatography Instruments
      • 7.1.1.3. Breath Analyzers
    • 7.1.2. Consumables
      • 7.1.2.1. Rapid Test Kits
      • 7.1.2.2. Reagents
      • 7.1.2.3. Others
    • 7.1.3. Latin America Drugs of Abuse Testing Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
      • 7.1.3.1. Saliva
      • 7.1.3.2. Urine
      • 7.1.3.3. Hair
      • 7.1.3.4. Breath
      • 7.1.3.5. Blood
      • 7.1.3.6. Sweat
    • 7.1.4. Latin America Drugs of Abuse Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
      • 7.1.4.1. Medical Screening
      • 7.1.4.2. Monitoring Pain Management
      • 7.1.4.3. Forensic & Legal Information
      • 7.1.4.4. Employment Drug Testing
      • 7.1.4.5. Sports & Athletics Testing
    • 7.1.5. Latin America Drugs of Abuse Testing Market Outlook, by End-User, Value (US$ Bn), 2020-2033
      • 7.1.5.1. Hospital
      • 7.1.5.2. Forensic Labs
      • 7.1.5.3. Diagnostic Centres
      • 7.1.5.4. Speciality Clinics
      • 7.1.5.5. Others
    • 7.1.6. Latin America Drugs of Abuse Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 7.1.6.1. Brazil Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 7.1.6.2. Brazil Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 7.1.6.3. Brazil Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 7.1.6.4. Brazil Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 7.1.6.5. Mexico Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 7.1.6.6. Mexico Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 7.1.6.7. Mexico Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 7.1.6.8. Mexico Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 7.1.6.9. Argentina Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 7.1.6.10. Argentina Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 7.1.6.11. Argentina Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 7.1.6.12. Argentina Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 7.1.6.13. Rest of LATAM Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 7.1.6.14. Rest of LATAM Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 7.1.6.15. Rest of LATAM Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 7.1.6.16. Rest of LATAM Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
    • 7.1.7. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Drugs of Abuse Testing Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Drugs of Abuse Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Equipment
      • 8.1.1.1. Immunoassay Analyzers
      • 8.1.1.2. Chromatography Instruments
      • 8.1.1.3. Breath Analyzers
    • 8.1.2. Consumables
      • 8.1.2.1. Rapid Test Kits
      • 8.1.2.2. Reagents
      • 8.1.2.3. Others
    • 8.1.3. Middle East & Africa Drugs of Abuse Testing Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
      • 8.1.3.1. Saliva
      • 8.1.3.2. Urine
      • 8.1.3.3. Hair
      • 8.1.3.4. Breath
      • 8.1.3.5. Blood
      • 8.1.3.6. Sweat
    • 8.1.4. Middle East & Africa Drugs of Abuse Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
      • 8.1.4.1. Medical Screening
      • 8.1.4.2. Monitoring Pain Management
      • 8.1.4.3. Forensic & Legal Information
      • 8.1.4.4. Employment Drug Testing
      • 8.1.4.5. Sports & Athletics Testing
    • 8.1.5. Middle East & Africa Drugs of Abuse Testing Market Outlook, by End-User, Value (US$ Bn), 2020-2033
      • 8.1.5.1. Hospital
      • 8.1.5.2. Forensic Labs
      • 8.1.5.3. Diagnostic Centres
      • 8.1.5.4. Speciality Clinics
      • 8.1.5.5. Others
    • 8.1.6. Middle East & Africa Drugs of Abuse Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 8.1.6.1. GCC Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 8.1.6.2. GCC Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 8.1.6.3. GCC Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 8.1.6.4. GCC Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 8.1.6.5. South Africa Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 8.1.6.6. South Africa Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 8.1.6.7. South Africa Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 8.1.6.8. South Africa Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 8.1.6.9. Egypt Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 8.1.6.10. Egypt Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 8.1.6.11. Egypt Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 8.1.6.12. Egypt Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 8.1.6.13. Nigeria Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 8.1.6.14. Nigeria Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 8.1.6.15. Nigeria Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 8.1.6.16. Nigeria Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
      • 8.1.6.17. Rest of Middle East Drugs of Abuse Testing Market Outlook, by Product, 2020-2033
      • 8.1.6.18. Rest of Middle East Drugs of Abuse Testing Market Outlook, by Sample Type, 2020-2033
      • 8.1.6.19. Rest of Middle East Drugs of Abuse Testing Market Outlook, by Application, 2020-2033
      • 8.1.6.20. Rest of Middle East Drugs of Abuse Testing Market Outlook, by End-User, 2020-2033
    • 8.1.7. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Siemens Healthineers AG
    • 9.4.3. Hoffmann-La Roche Ltd (Roche Diagnostics)
    • 9.4.4. Quest Diagnostics Incorporated
    • 9.4.5. Bio-Rad Laboratories, Inc.
    • 9.4.6. Dragerwerk AG & Co. KGaA
    • 9.4.7. Shimadzu Corporation
    • 9.4.8. Randox Laboratories Ltd.
    • 9.4.9. Psychemedics Corporation
    • 9.4.10. Laboratory Corporation of America Holdings (LabCorp)

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!